Authorization Not Approval for All Future Jabs?

This does seem to be the direction jab use is taking. Nothing approved, every new concoction largely untested and unproven. And why not? Since there is no liability. No accountability. Does it really matter to the pharmaceutical manufacturer? Why would it?

It should matter to YOU the jab recipient. Though, apparently the authorized, “emergency use authorization”, covid jab, never approved through conventional safety testing didn’t stop multi millions of people being injected multiple times..

Here we go again.. Pfizer and BioNTech Apply to FDA for Emergency Use Authorization of Omicron-Adapted COVID-19 Booster Vaccine.

Not properly approved. Not safety tested in the usual conventional manner, just authorized for emergency use. Again.

Is this still an emergency? It doesn’t seem so. However the idea of an ‘emergency’ sure gives Pfizer and BioNTech a real advantage, a financial incentive to get jab after jab to the market and into the arm of the test subject. And if a whole bunch die or are injured- NO LIABILITY!

Pfizer and BioNTech have submitted an application to the FDA for Emergency Use Authorization (EUA) for an Omicron-adapted bivalent COVID-19 vaccine, following positive data (provided by big pharma- conflict of interest much?) showing its efficacy.

Data support the request for an EUA of a 30-µg booster dose of an Omicron-adapted bivalent COVID-19 vaccine in individuals 12 years of age and older. The companies have rapidly scaled production and are prepared to deliver doses of the vaccine for September, and will begin shipping immediately pending authorization, according to a press release.

In other words the EUA is the rubber stamp to get the plebes (uneducated or uncultured, the masses) jabbed.

“The agility of the mRNA platform, together with extensive clinical experience with the Pfizer-BioNTech COVID-19 vaccine, has allowed us to develop, test, and manufacture updated, high-quality vaccines that align to circulating strains with unprecedented speed,” said Albert Bourla, chairman and CEO of Pfizer, in the press release. “Having rapidly scaled up production, we are positioned to immediately begin distribution of the bivalent Omicron BA.4/BA.5 boosters, if authorized, to help protect individuals and families as we prepare for potential fall and winter surges.”

Help protect? Just like the initial Pfizer jab did? That’s funny! Was it supposed to be? Feels like some sort of bad comedy

Of course the companies who are looking for authorization rather than approval claim their jab is safe

The companies previously announced safety, tolerability, and immunogenicity data from a phase 2/3 trial of a 30-µg booster dose of the Omicron BA.1-adapted bivalent vaccine candidate, which combines the existing vaccine and a vaccine targeting the Omicron BA.1 variant spike protein. This vaccine elicited a superior immune response against the Omicron BA.1 variant compared to the companies’ current COVID-19 vaccine. It was also well-tolerated with a favorable safety profile.

According to the company…

If it’s safe why not go through the normal long term safety testing and gather an abundance of data while allowing for appropriate scrutiny of said safety studies? Thereby ensuring as much as possible the safety of these products before they insinuate their ingredients into the human body and all it’s glorious natural intricacies.

Leave a Reply